Chinese drug maker Akeso, whose new cancer drug has outperformed a leading Western peer in clinical studies, is being hailed ...

The signs of WuXi AppTec's performance rebound were evident last quarter, with its net profit soaring 91 percent to CNY2.9 ...

American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...

Chinese stocks ended higher, supported by home appliance and pharma stocks. Despite the impact of China's ...

The competition between U.S. and Chinese biotech companies is particularly fierce in one field: CRISPR gene editing. Here are ...

Insilico Medicine, whose Hong Kong IPO application lapsed in 2024, is still considering going public in the city, said ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

They provide leverage that Trump should use to strike a deal with China to more comprehensively regulate its pharmaceutical ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

According to data from DealForma, as reported by CNBC, around 30% of Big Pharma deals with at least $50 million upfront in ...

According to data from DealForma, as reported by CNBC, around 30% of Big Pharma deals with at least $50 million upfront in 2024 included Chinese companies. This was up from 20% the year before and ...